Guidelines for the general management of patients with acute ischemic stroke

Yeu Jhy Chang, Shan Jin Ryu, Jiunn Rong Chen, Han Hwa Hu, Ping Keung Yip, Te Fa Chiu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The content of the second edition of "Guideline for General Management of Patients with Acute Ischemic Stroke" was amended from the first edition of that of the Taiwan Stroke Society in 2002. The format of the guideline followed the common unified instruction for the project of "The establishment of clinical guidelines for the top 10 payments diseases of the National Health Insurance at the departments of inpatients, emergency and outpatients" as recommended by the National Health Research Institutes (NHRI). The guideline was revised after several official meetings of local experts, as well as citation from the latest updated guidelines of the United States and the European Stroke academic groups. Before editing notice, the final evaluation was performed by the review team of the NHRI. Application of the guideline is dedicated or designated to the patients with acute ischemic stroke, and which is applied only limited to the general management. Guidelines for subacute or chronic phase, or the specific treatment for ischemic stroke patients will be published in separated articles. Management of most of the needs for patients with acute ischemic stroke must be completed in a very short period of time. It is recommended that hospitals providing stroke service to set up stroke unit, and to organize an integrated stroke team consisting of specialists from multiple disciplines. Upon arrival to the hospitals, patients should undergo the brain computed tomography, and related examinations and assessment as soon as possible to guide the choice of treatment reference for acute intervention. Intravenous recombinant tissue plasminogen activator treatment within three hours is effective in reducing disability for patients with acute ischemic stroke. Ischemic stroke patients with or without persistent symptoms should start antiplatelet therapy immediately, generally aspirin. Dose-adjusted warfarin (INR range of 2.0-3.0) is recommended for ischemic stroke patients with persistent or paroxysmal atrial fibrillation to prevent secondary embolism. The routine use of heparin and drugs theoretically preventing further brain injury, including steroids, neuroprotectants, plasma volume expanders, barbiturates, and streptokinase, has not been proven benefits for recommendation.

Original languageEnglish
Pages (from-to)275-295
Number of pages21
JournalActa Neurologica Taiwanica
Volume17
Issue number4
Publication statusPublished - Dec 1 2008
Externally publishedYes

Fingerprint

Stroke
Guidelines
Atrial Fibrillation
Plasma Substitutes
Barbiturates
Streptokinase
International Normalized Ratio
Health
National Health Programs
Neuroprotective Agents
Tissue Plasminogen Activator
Warfarin
Therapeutics
Embolism
Taiwan
Brain Injuries
Aspirin
Heparin
Hospital Emergency Service
Inpatients

Keywords

  • Acute ischemic stroke
  • General management
  • Taiwan guidelines

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Chang, Y. J., Ryu, S. J., Chen, J. R., Hu, H. H., Yip, P. K., & Chiu, T. F. (2008). Guidelines for the general management of patients with acute ischemic stroke. Acta Neurologica Taiwanica, 17(4), 275-295.

Guidelines for the general management of patients with acute ischemic stroke. / Chang, Yeu Jhy; Ryu, Shan Jin; Chen, Jiunn Rong; Hu, Han Hwa; Yip, Ping Keung; Chiu, Te Fa.

In: Acta Neurologica Taiwanica, Vol. 17, No. 4, 01.12.2008, p. 275-295.

Research output: Contribution to journalArticle

Chang, YJ, Ryu, SJ, Chen, JR, Hu, HH, Yip, PK & Chiu, TF 2008, 'Guidelines for the general management of patients with acute ischemic stroke', Acta Neurologica Taiwanica, vol. 17, no. 4, pp. 275-295.
Chang YJ, Ryu SJ, Chen JR, Hu HH, Yip PK, Chiu TF. Guidelines for the general management of patients with acute ischemic stroke. Acta Neurologica Taiwanica. 2008 Dec 1;17(4):275-295.
Chang, Yeu Jhy ; Ryu, Shan Jin ; Chen, Jiunn Rong ; Hu, Han Hwa ; Yip, Ping Keung ; Chiu, Te Fa. / Guidelines for the general management of patients with acute ischemic stroke. In: Acta Neurologica Taiwanica. 2008 ; Vol. 17, No. 4. pp. 275-295.
@article{175b7d7afd21437ea9eeb32eabad25b3,
title = "Guidelines for the general management of patients with acute ischemic stroke",
abstract = "The content of the second edition of {"}Guideline for General Management of Patients with Acute Ischemic Stroke{"} was amended from the first edition of that of the Taiwan Stroke Society in 2002. The format of the guideline followed the common unified instruction for the project of {"}The establishment of clinical guidelines for the top 10 payments diseases of the National Health Insurance at the departments of inpatients, emergency and outpatients{"} as recommended by the National Health Research Institutes (NHRI). The guideline was revised after several official meetings of local experts, as well as citation from the latest updated guidelines of the United States and the European Stroke academic groups. Before editing notice, the final evaluation was performed by the review team of the NHRI. Application of the guideline is dedicated or designated to the patients with acute ischemic stroke, and which is applied only limited to the general management. Guidelines for subacute or chronic phase, or the specific treatment for ischemic stroke patients will be published in separated articles. Management of most of the needs for patients with acute ischemic stroke must be completed in a very short period of time. It is recommended that hospitals providing stroke service to set up stroke unit, and to organize an integrated stroke team consisting of specialists from multiple disciplines. Upon arrival to the hospitals, patients should undergo the brain computed tomography, and related examinations and assessment as soon as possible to guide the choice of treatment reference for acute intervention. Intravenous recombinant tissue plasminogen activator treatment within three hours is effective in reducing disability for patients with acute ischemic stroke. Ischemic stroke patients with or without persistent symptoms should start antiplatelet therapy immediately, generally aspirin. Dose-adjusted warfarin (INR range of 2.0-3.0) is recommended for ischemic stroke patients with persistent or paroxysmal atrial fibrillation to prevent secondary embolism. The routine use of heparin and drugs theoretically preventing further brain injury, including steroids, neuroprotectants, plasma volume expanders, barbiturates, and streptokinase, has not been proven benefits for recommendation.",
keywords = "Acute ischemic stroke, General management, Taiwan guidelines",
author = "Chang, {Yeu Jhy} and Ryu, {Shan Jin} and Chen, {Jiunn Rong} and Hu, {Han Hwa} and Yip, {Ping Keung} and Chiu, {Te Fa}",
year = "2008",
month = "12",
day = "1",
language = "English",
volume = "17",
pages = "275--295",
journal = "Acta Neurologica Taiwanica",
issn = "1019-6099",
publisher = "Taiwan Neurological Society",
number = "4",

}

TY - JOUR

T1 - Guidelines for the general management of patients with acute ischemic stroke

AU - Chang, Yeu Jhy

AU - Ryu, Shan Jin

AU - Chen, Jiunn Rong

AU - Hu, Han Hwa

AU - Yip, Ping Keung

AU - Chiu, Te Fa

PY - 2008/12/1

Y1 - 2008/12/1

N2 - The content of the second edition of "Guideline for General Management of Patients with Acute Ischemic Stroke" was amended from the first edition of that of the Taiwan Stroke Society in 2002. The format of the guideline followed the common unified instruction for the project of "The establishment of clinical guidelines for the top 10 payments diseases of the National Health Insurance at the departments of inpatients, emergency and outpatients" as recommended by the National Health Research Institutes (NHRI). The guideline was revised after several official meetings of local experts, as well as citation from the latest updated guidelines of the United States and the European Stroke academic groups. Before editing notice, the final evaluation was performed by the review team of the NHRI. Application of the guideline is dedicated or designated to the patients with acute ischemic stroke, and which is applied only limited to the general management. Guidelines for subacute or chronic phase, or the specific treatment for ischemic stroke patients will be published in separated articles. Management of most of the needs for patients with acute ischemic stroke must be completed in a very short period of time. It is recommended that hospitals providing stroke service to set up stroke unit, and to organize an integrated stroke team consisting of specialists from multiple disciplines. Upon arrival to the hospitals, patients should undergo the brain computed tomography, and related examinations and assessment as soon as possible to guide the choice of treatment reference for acute intervention. Intravenous recombinant tissue plasminogen activator treatment within three hours is effective in reducing disability for patients with acute ischemic stroke. Ischemic stroke patients with or without persistent symptoms should start antiplatelet therapy immediately, generally aspirin. Dose-adjusted warfarin (INR range of 2.0-3.0) is recommended for ischemic stroke patients with persistent or paroxysmal atrial fibrillation to prevent secondary embolism. The routine use of heparin and drugs theoretically preventing further brain injury, including steroids, neuroprotectants, plasma volume expanders, barbiturates, and streptokinase, has not been proven benefits for recommendation.

AB - The content of the second edition of "Guideline for General Management of Patients with Acute Ischemic Stroke" was amended from the first edition of that of the Taiwan Stroke Society in 2002. The format of the guideline followed the common unified instruction for the project of "The establishment of clinical guidelines for the top 10 payments diseases of the National Health Insurance at the departments of inpatients, emergency and outpatients" as recommended by the National Health Research Institutes (NHRI). The guideline was revised after several official meetings of local experts, as well as citation from the latest updated guidelines of the United States and the European Stroke academic groups. Before editing notice, the final evaluation was performed by the review team of the NHRI. Application of the guideline is dedicated or designated to the patients with acute ischemic stroke, and which is applied only limited to the general management. Guidelines for subacute or chronic phase, or the specific treatment for ischemic stroke patients will be published in separated articles. Management of most of the needs for patients with acute ischemic stroke must be completed in a very short period of time. It is recommended that hospitals providing stroke service to set up stroke unit, and to organize an integrated stroke team consisting of specialists from multiple disciplines. Upon arrival to the hospitals, patients should undergo the brain computed tomography, and related examinations and assessment as soon as possible to guide the choice of treatment reference for acute intervention. Intravenous recombinant tissue plasminogen activator treatment within three hours is effective in reducing disability for patients with acute ischemic stroke. Ischemic stroke patients with or without persistent symptoms should start antiplatelet therapy immediately, generally aspirin. Dose-adjusted warfarin (INR range of 2.0-3.0) is recommended for ischemic stroke patients with persistent or paroxysmal atrial fibrillation to prevent secondary embolism. The routine use of heparin and drugs theoretically preventing further brain injury, including steroids, neuroprotectants, plasma volume expanders, barbiturates, and streptokinase, has not been proven benefits for recommendation.

KW - Acute ischemic stroke

KW - General management

KW - Taiwan guidelines

UR - http://www.scopus.com/inward/record.url?scp=58149305713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149305713&partnerID=8YFLogxK

M3 - Article

C2 - 19280874

AN - SCOPUS:58149305713

VL - 17

SP - 275

EP - 295

JO - Acta Neurologica Taiwanica

JF - Acta Neurologica Taiwanica

SN - 1019-6099

IS - 4

ER -